Donor management and lung preservation for lung transplantation

The Lancet Respiratory Medicine

Volumn 1, Issue 4, 2013, Pages 318-328

  Munshi, Laveena ^a   Keshavjee, Shaf ^a   Cypel, Marcelo ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; ADRENALIN; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CATECHOLAMINE; CELSIOR; DESMOPRESSIN; DEXTRAN 40; DOPAMINE; EUROCOLLINS SOLUTION; GLUCOCORTICOID; GLUCOSE; HEPARIN; HYPERTENSIVE FACTOR; INOTROPIC AGENT; INTERLEUKIN 10; LIOTHYRONINE; LOW POTASSIUM DEXTRAN SOLUTION; METHYLPREDNISOLONE; NORADRENALIN; OXYGEN; PERFADEX; PHENYLEPHRINE; PLACEBO; PRESERVATION SOLUTION; PROSTAGLANDIN E1; SALBUTAMOL; STEROID; THYROXINE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VASOPRESSIN;

AGE DISTRIBUTION; ANTEROGRADE FLUSHING; BRAIN DEATH; CAPILLARY LEAK SYNDROME; CENTRAL VENOUS PRESSURE; CLINICAL PROTOCOL; COLD ISCHEMIA; DIABETES INSIPIDUS; DONATION AFTER CARDIAC DEATH; DONOR LUNG PRESERVATION; DONOR SELECTION; DRUG ACTIVITY; DRUG CHOICE; ELECTROCARDIOGRAPHY; ENDOCRINE DISEASE; EUTHYROID SICK SYNDROME; EX VIVO LUNG PERFUSION SYSTEM; HEART DEATH; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HORMONAL THERAPY; HORMONE DEFICIENCY; HUMAN; HYPOTHYROIDISM; HYPOVOLEMIA; INTENSIVE CARE; LUNG EDEMA; LUNG INJURY; LUNG INSUFFICIENCY; LUNG PERFUSION; LUNG TRANSPLANTATION; LUNG VASOCONSTRICTION; LUNG VENTILATION; MEDICAL DEVICE; NEBULIZATION; NONHUMAN; NORMOTHERMIC EX VIVO LUNG PERFUSION; ORGAN DONOR; OSMOTIC DIURESIS; OXYGENATION; PERFUSION PRESSURE; POSITIVE END EXPIRATORY PRESSURE; POSTOPERATIVE COMPLICATION; PRIMARY GRAFT DYSFUNCTION; PRIORITY JOURNAL; RESUSCITATION; RETROGRADE FLUSHING; REVIEW; SAFETY; SHOCK; SMOKING; STANDARDIZATION; STORAGE TEMPERATURE; SURGICAL MORTALITY; SURVIVAL RATE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TIDAL VOLUME; TISSUE PRESERVATION; TOTAL LUNG CAPACITY; VENTILATOR INDUCED LUNG INJURY; VIRAL GENE THERAPY;

HUMANS; LUNG TRANSPLANTATION; ORGAN PRESERVATION; RESPIRATORY INSUFFICIENCY; TISSUE DONORS; WAITING LISTS;

EID: 84880045999     PISSN: 22132600     EISSN: None     Source Type: Journal    
DOI: 10.1016/S2213-2600(12)70064-4     Document Type: Review

References (83)

1. King R, Binns O, Rodriguez F, et al. Reperfusion injury significantly impacts clinical outcome after pulmonary transplantation. Ann Thor Surg 2000, 69:1681.
2. Lee J, Christie J, Keshavjee S Primary graft dysfunction: definition, risk factors, short-and long-term outcomes. Semin Respir Crit Care Med 2010, 31:161-171.
3. Orends J, Boehler A, de Perrot M, et al. A review of lung transplant donor acceptability criteria: consensus report from the Pulmonary Council of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 2003, 22:1183-1200.
4. De Perrot M, Waddell TK, Shargall Y, et al. Impact of donors aged 60 years or more on outcome after lung transplantation: results of an 11 year single-center experience. J Thorac Cardiovasc Surg 2006, 133:525-531.
5. Oto T, Griffiths AP, Levvey B, et al. A donor history of smoking affects early but not late outcomes in lung transplantation. Transplantation 2004, 78:599-606.
6. Bonser RS, Taylor R, Collett D, Thomas HL, Dark JH, Neuberger J Effect of donor smoking on survival after lung transplantation: a cohort study of a prospective registry. Lancet 2012, 380:747-755.
7. Tamm M, Higenbottam TW, Dennis CM, Sharples LD, Wallwork J Donor and recipient predicted lung volume and lung size after heart-lung transplantation. Am J Respir Crit Care Med 1994, 150:403-407.
8. Pierre AF, Keshavjee S Lung transplantation: donor and recipient critical care aspects. Curr Opin Crit Care 2005, 11:339-344.
9. Shemie SD, Ross H, Pagliarello J, et al. Organ donor management in Canada: recommendations of the forum on Medical Management to Optimize Donor Organ Potential. CMAJ 2006, 174:13-32.
10. Van Raemdonck D, Neyrinck A, Verleden G, et al. Lung donor selection and management. Proc Am Thorac Soc 2009, 6:28-38.
11. Punch J, Hayes D, LaPorte F, McBride V, Seely M Organ donation and utilization in the United States 1996-2005. Am J Transplant 2007, 7:1327-1338.
12. Determann R, Royakkers A, Wolthuis E, et al. Ventilation with lower tidal volumes as compared with conventional tidal volumes for patients without acute lung injury: a preventive randomized controlled trial. Crit Care 2010, 14:R1.
13. Ventilation with lower tidal volumes compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 2000, 342:1301-1308. The Acute Respiratory Distress Syndrome Network.
14. Mascia L, Pasero D, Slutsky A, et al. Effect of a lung protective strategy for organ donors on eligibility and availability of lungs for transplantation. JAMA 2010, 304:2620-2627.
15. Wood K, Becker B, McCartney J, D'Alessandro A, Coursin D Care of the potential organ donor. N Engl J Med 2004, 351:2730-2739.
16. Pratschke J, Wilhelm M, Kusaka M, Hancock W, Tilney N Activation of proinflammatory genes in somatic organs as a consequence of brain death. Transplant Proc 1999, 31:1003-1005.
17. Rivers E, Nguyen B, Havstad S, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001, 345:1368-1377.
18. Pennefather S, Bullock R, Mantle D, Dark J Use of low dose arginine vasopressin to support brain-dead donors. Transplantation 1995, 56:58-62.
19. Tuttle-Newhall J, Collins B, Kuo P, Schoeder R Organ donation and treatment of multi-organ donor. Curr Prob Surg 2003, 40:266-310.
20. Minambres E, Rodrigo E, Ballesteros M, et al. Impact of restrictive fluid balance focused to increase lung procurement on renal function after kidney transplantation. Nephrol Dial Transplant 2010, 25:2352-2356.
21. Finfer S, Bellomo R, Boyce N, French J, Myburgh J, Norton R A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 2004, 350:2247-2256. SAFE Study Investigators.
22. Bayer O, Reinhart K, Kohl M, et al. Effects of fluid resuscitation with synthetic colloids or crystalloids alone on shock reversal, fluid balance and patient outcomes in patients with severe sepsis: a prospective sequential analysis. Crit Care Med 2012, 40:2543-2551.
23. Braunwald E, Wagner HJ The pressor effect of the antidiuretic principle of the posterior pituitary in orthostatic hypotension. J Clin Invest 1956, 35:1412-1418.
24. Chen J, Cullinane S, Spanier T, et al. Vasopressin deficiency and pressor hypersensitivity in hemodynamically unstable organ donors. Circulation 1999, 100(suppl 2):246.
25. Mukadam M, Harrington D, Wilson I, et al. Does donor catecholamine administration affect early lung function after transplantation?. J Thorac Cardiovasc Surg 2005, 130:926-927.
26. Howlett T, Keogh A, Perry L, Touzel R, Rees L Anterior and posterior pituitary function in brain-stem-dead donors: a possible role for hormonal replacement therapy. Transplantation 1989, 47:828-834.
27. Powner D, Hendrich A, Lagler R, Ng R, Madden R Hormonal changes in brain dead patients. Crit Care Med 1990, 18:702-708.
28. Gramm H, Meinhold H, Bickel U, et al. Acute endocrine failure after brain death?. Transplantation 1992, 54:851-857.
29. Goarin J, Cohen S, Riou B, et al. The effects of triiodothyronine on hemodynamic status and cardiac function in potential heart donors. Anesth Analg 1996, 83:41-47.
30. Shemie S, Ross H, Pagliarello J, et al. Organ donor management in Canada: recommendations of the forum on medical management to optimize donor organ potential. CMAJ 2006, 174:S13-S30.
31. Dimopoulou I, Tsagarakis S, Anthi A, et al. High prevalence of decreased cortisol reserve in brain-dead potential organ donors. Crit Care Med 2003, 31:1113.
32. Follette D, Rudich S, Babcock W Improved oxygenation and increased lung donor recovery with high-dose steroid administration after brain death. J Heart Lung Transplant 1998, 17:423-429.
33. Venkateswaran R, Patchell V, Wilson I, et al. Early donor management increases the retrieval rate of lungs for transplantation. Ann Thorac Surg 2008, 85:278-286.
34. Salim A, Martin M, Brown C, et al. Using thyroid hormone in brain-dead donors to maximize the number of organs available for transplantation. Clin Transplant 2007, 21:405-409.
35. Rosendale J, Kauffman H, McBride M, et al. Hormonal resuscitation yields more transplanted hearts with improved early function. Transplantation 2003, 75:1336-1341.
36. Macdonald P, Aneman A, Bhonagiri D, et al. A systematic review and meta-analysis of clinical trials of thyroid hormone administration to brain dead potential organ donors. Crit Care Med 2012, 40:1635-1645.
37. Rosengard B, Feng S, Alfrey E, et al. Report of the Crystal City meeting to maximize the use of organs recovered from the cadaver donor. Am J Transplant 2002, 2:701-711.
38. Sakuma T, Folkesson H, Suzuki S, Okaniwa G, Fujimura S, Matthay M Beta adrenergic agonist stimulated alveolar fluid clearance in ex vivo human and rat lungs. Am J Respir Crit Care Med 1997, 155:506-512.
39. Ware L, Fang X, Wang Y, Sakuma T, Hall T, Matthay M Selected contribution: mechanisms that may stimulate the resolution of alveolar edema in the transplanted human lung. J Appl Physiol 2002, 93:1869-1874.
40. Ware L A randomized trial of nebulized albuterol to enhance resolution of pulmonary edema in 506 brain dead organ donors. J Heart Lung Transplant 2012, 31(suppl 4):116.
41. Franklin G, Santos A, Smith J, Galbraith S, Harbrecht B, Garrison R Optimization of donor management goals yields increased organ use. Am Surg 2010, 76:587-595.
42. Christmas A, Bogart T, Etson K, et al. The reward is worth the wait: a prospective analysis of 100 consecutive organ donors. Am Surg 2012, 78:296-300.
43. De Oliveira N, Osaki S, Maloney J, et al. Lung transplantation with donation after cardiac death donors: long-term follow-up in a single center. J Thorac Cardiovasc Surg 2010, 139:1306.
44. Oto T, Excell L, Griffiths A, et al. Association between primary graft dysfunction among lung, kidney and heart recipients from the same multi-organ donor. Am J Transplant 2008, 8:2132-2139.
45. Levvey B, Harkess M, Hopkins P, et al. Excellent clinical outcomes from a national donation after determination of cardiac death lung transplant collaborative. Am J Transplant 2012, 12:2406-2413.
46. Lewis J, Peltier J, Nelson H, et al. Development of the University of Wisconsin donation after cardiac death evaluation tool. Prog Transplant 2003, 13:265-273.
47. Venuta F, Rendina E, Bufi M, et al. Preimplantation retrograde pneumoplegia in clinical lung transplantation. J Thorac Cardiovasc Surg 1999, 118:107.
48. Van De Wauwer C, Neyrinck AP, Geudens N, et al. Retrograde flush following warm ischemia in the non-heart-beating donor results in superior graft performance at reperfusion. J Surg Res 2009, 154:118-125.
49. Haverich A, Aziz S, Scott W, Jamieson S, Shumway N Improved lung preservation using Euro-Collins solution for flush perfusion. Thorac Cardiovasc Surg 1986, 34:368-376.
50. Steen S, Sjöberg T, Massa G, Ericsson L, Lindberg L Safe pulmonary preservation for 12 hours with low-potassium-dextran solution. Ann Thorac Surg 1993, 55:434-440.
51. De Perrot M, Bonser R, Dark J, et al. Report of the ISHLT working group on primary lung graft dysfunction part II: donor-related risk factors and markers. J Heart Lung Transplant 2005, 24:1460-1468.
52. Sasaki M, Muraoka R, Chiba Y, Hiramatu Y Influence of pulmonary arterial pressure during flushing on lung preservation. Transplantation 1996, 61:22-27.
53. Fujimura S, Handa M, Kondo T, Ichinose T, Shiraishi Y, Nakada T Successful 48 hour simple hypothermic preservation of canine lung transplants. Transplant Proc 1987, 19:1334-1336.
54. Keshavjee S, Yamazaki F, Cardoso P, McRitchie D, Patterson G, Cooper J A method for safe twelve-hour pulmonary preservation. J Thorac Cardiovasc Surg 1989, 98:529-534.
55. Date H, Matsumura A, Manchester J, et al. Evaluation of lung metabolism during successful twenty-four hour canine lung preservation. J Thorac Cardiovasc Surg 1993, 105:480-491.
56. Arnaoutakis G, Allen J, Merlo C, Baumgartner W, Conte J, Shah A Low potassium dextran is superior to University of Wisconsin solution in high-risk lung transplant recipients. J Heart Lung Transplant 2010, 29:1380-1387.
57. Thabut G, Vinatier I, Brugière O, et al. Influence of preservation solution on early graft failure in clinical lung transplantation. Am J Respir Crit Care Med 2001, 164:1204-1208.
58. Rabanal J, Ibañez A, Mons R, et al. Influence of preservation solution on early lung function. Transplant Proc 2003, 35:1938-1939.
59. Fischer S, Matte-Martyn A, De Perrot M, et al. Low-potassium dextran preservation solution improves lung function after human lung transplantation. J Thorac Cardiovasc Surg 2001, 121:594-596.
60. Struber M, Wilhelmi M, Harringer W, et al. Flush perfusion with low potassium dextran solution improves early graft function in clinical lung transplantation. Eur J Cardiothorac Surg 2001, 19:190-194.
61. Muller C, Fürst H, Reichenspurner H, Briegel J, Groh J, Reichart B Lung procurement by low-potassium dextran and the effect on preservation injury. Munich Lung Transplant Group. Transplantation 1999, 68:1139-1143.
62. Stevens G, Sanchez M, Chappell G Enhancement of lung preservation by prevention of lung collapse. J Surg Res 1973, 14:400-405.
63. Sakuma T, Tsukano C, Ishigaki M, et al. Lung deflation impairs alveolar epithelial fluid transport in ischemic rabbit and rat lungs. Transplantation 2000, 69:1785-1793.
64. Baretti R, Bitu-Moreno J, Beyersdorf F, Matheis G, Francischetti I, Kreitmayr B Distribution of lung preservation solutions in parenchyma and airways: influence of atelectasis and route of delivery. J Heart Lung Transplant 1995, 14:80-91.
65. DeCampos K, Keshavjee S, Liu M, Slutsky A Optimal inflation volume for hypothermic preservation of rat lungs. J Heart Lung Transplant 1998, 17:599-607.
66. Haniuda M, Dresler C, Mizuta T, Cooper J, Patterson G Free radical-mediated vascular injury in lungs preserved at moderate hypothermia. Ann Thorac Surger 1995, 60:1376-1381.
67. Kayano K, Toda K, Naka Y, Pinsky DJ Identification of optimal conditions for lung graft storage with Euro-Collins solution by use of a rat orthotopic lung transplant model. Circulation 1999, 100(suppl 19):257-261.
68. De Perrot M, Fischer S, Liu M, et al. Prostaglandin E1 protects lung transplants from ischemia-reperfusion injury: a shift from pro- to anti-inflammatory cytokines. Transplantation 2001, 72:1505-1512.
69. Erasmus M, Fernhout M, Elstrodt J, Rakhorst G Normothermic ex vivo lung perfusion of non-heart-beating donor lungs in pigs: from pretransplant function analysis towards a 6-h machine preservation. Transpl Int 2006, 19:589-593.
70. Novick R, Bennett L, Meyer D, Hosenpud J Influence of graft ischemic time and donor age on survival after lung transplantation. J Heart Lung Transplant 1999, 18:425-431.
71. De Perrot M, Liu M, Waddell T, Keshavjee S Ischemia-reperfusion induced lung injury. Am J Respir Crit Care Med 2003, 167:490-511.
72. Thabut G, Mal H, Cerrina J, et al. Graft ischemic time and outcome of lung transplantation: a multicenter analysis. Am J Respir Crit Care Med 2005, 171:786-791.
73. Lee J, Christie J Primary graft dysfunction. Clin Chest Med 2011, 32:279-293.
74. Steen S, Liao Q, Wierup P, Bolys R, Pierre L, Sjöberg T Transplantation of lungs from non-heart-beating donors after functional assessment ex-vivo. Ann Thorac Surg 2003, 76:244-252.
75. Cypel M, Yeung J, Liu M, et al. Normothermic ex vivo lung perfusion in clinical lung transplantation. N Engl J Med 2011, 364:1431-1440.
76. Cypel M, Yeung J, Machuca T, et al. Experience with the first 50 ex vivo lung perfusions in clinical transplantation. J Thorac Cardiovasc Surg 2012, 144:1200-1207.
77. Yeung J, Cypel M, Machuca T, et al. Physiologic assessment of the ex vivo donor lung for transplantation. J Heart Lung Transplant 2012, 31:1120-1126.
78. Warnecke G, Moradiellos J, Tudorache I, et al. Normothermic perfusion of donor lungs for preservation and assessment with the Organ Care System Lung before bilateral transplant: a pilot study of 12 patients. Lancet 2012, 380:1851-1858.
79. Bonato R Ex vivo treatment of infection in human donor lungs. J Heart Lung Transplant 2012, 31:S97.
80. Karamanou D The effect of ex vivo perfusion on the microbiological profile of the donor lung. J Heart Lung Transplant 2010, 29(suppl 2):S94.
81. Cypel M, Liu M, Ruchacha M, et al. Functional repair of human donor lungs by IL-10 gene therapy. Sci Transl Med 2009, 1:4-9.
82. Lee J, Fang X, Gupta N, Serikov V, Matthay M Allogeneic human mesenchymal stem cells for treatment of E. coli endotoxin-induced acute lung injury in the ex vivo perfused human lung. Proc Natl Acad Sci USA 2009, 106:16357-16362.
83. Wigfield C, Cypel M, Yeung J, et al. Successful emergent lung transplantation after remote ex vivo perfusion optimization and transportation of donor lungs. Am J Transplant 2012, 12:2838-2844.